Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Dec 10, 2020 12:23am
96 Views
Post# 32074481

RE:RE:RE:RE:Sigilon

RE:RE:RE:RE:Sigilon Bio you said the exact same thing about Viacyte.  Then it was Vertex and yet still after all these years here we sit the only ones in the clinic showing positive results.  That's a fact.  So let's just keep talking about poor decisions and that Trout solesbury the Leading IR in specialty pharma and medical device companies was used by two companies in that field. What relevance does this have?  Did Troute sabotage Sernova and we are still feeling the effects 2 years later?   Reality is they are a large firm that doesn't care who gives them money they will help with IPO's or whatever is needed if they are paid.  Yes management has been poor but we dont need to be dumb about it. 
<< Previous
Bullboard Posts
Next >>